hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia.

hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia.

Telomere shortening is associated with disease progression in chronic myeloid leukaemia (CML). To investigate the biology and regulation of telomerase in CML, we evaluated expression of the telomerase components, its regulators and several telomeric-associated proteins. Quantitative real-time-polyme...

Full description

Bibliographic Details
Main Authors:	Campbell, L, Fidler, C, Eagleton, H, Peniket, A, Kusec, R, Gal, S, Littlewood, T, Wainscoat, J, Boultwood, J
Format:	Journal article
Language:	English
Published:	2006

Similar Items

Investigation of Boldine as a Potential Telomerase Inhibitor by Downregulation of hTERT/hTERC in HCT 116 Human Colon Carcinoma Cells
by: Ahmad, Nadhirah, et al.
Published: (2019)

IFN-α inhibits telomerase in human CD8⁺ T cells by both hTERT downregulation and induction of p38 MAPK signaling
by: Lanna, A, et al.
Published: (2013)

Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
by: Boultwood, J, et al.
Published: (2004)

Amplification of mitochondrial DNA in acute myeloid leukaemia.
by: Boultwood, J, et al.
Published: (1996)

Identification of mechanism of cancer-cell-specific reactivation of hTERT offers therapeutic opportunities for blocking telomerase specifically in human colorectal cancer
by: Akıncılar, Semih Can, et al.
Published: (2023)

Immunohistochemical localization of hTERT protein in oral carcinogenesis
by: Kumar, S., et al.
Published: (2005)

Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukaemia
by: Atoyebi, W, et al.
Published: (1997)

Characterising early human lympho-myeloid haematopoietic progenitors and their relationship with acute myeloid leukaemia stem cells
by: Aboukhalil, Z
Published: (2018)

Genes located within the del(9q) commonly deleted region are down-regualted in acute myeloid leukaemia.
by: Zhao, Z, et al.
Published: (2004)

Haematopoietic development and leukaemia in Down syndrome
by: Roberts, I, et al.
Published: (2014)

Regulation Of Telomerase Reverse Transcriptase (Tert) By The Leukaemic Fusion Gene Aml1/Eto
by: Moses, Emmanuel Jairaj
Published: (2015)

trt-1 is the Caenorhabditis elegans catalytic subunit of telomerase
by: Meier, B, et al.
Published: (2006)

Neutrophil gene expression in chronic myeloproliferative disorders.
by: Eagleton, H, et al.
Published: (2003)

Neutrophil PRV-1 gene expression in myeloproliferative, myelodysplastic and reactive blood disorders
by: Zhang, J, et al.
Published: (2004)

Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia.
by: Watkins, F, et al.
Published: (2004)

HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis
by: Bi, Xuezhi, et al.
Published: (2018)

HoxC5 and miR-615-3p target newly evolved genomic regions to repress hTERT and inhibit tumorigenesis
by: Yan, T, et al.
Published: (2018)

Molecular characterization of the 7q deletion in myeloid disorders.
by: Lewis, S, et al.
Published: (1996)

AMPLIFICATION OF MITOCHONDRIAL-DNA IN ACUTE MYELOID-LEUKEMIA
by: Boultwood, J, et al.
Published: (1994)

Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia.
by: Boultwood, J, et al.
Published: (1999)

Deciphering S-Phase Protein Kinase 2 (Skp2) Mediated Regulation Of Telomerase Reverse Transcriptase (Tert) In Kasumi-1, T (8;21) Acute Myeloid Leukemia (Aml) Cell Line
by: Rosli, Nur Aliaa Arina
Published: (2023)

MOLECULAR MAPPING OF THE 7Q-DELETION IN MYELOID DISORDERS
by: Lewis, S, et al.
Published: (1993)

Clonal structures of leukaemia stem cell populations in myeloid blast phase chronic myeloid leukaemia
by: Karamitros, D, et al.
Published: (2016)

Harnessing the graft-versus-leukaemia effect in acute myeloid leukaemia
by: Sweeney, C
Published: (2021)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
by: Boultwood, J, et al.
Published: (2009)

Investigation of haematopoietic cell growth and the impact of common mutations in myeloid malignancies
by: Tittrea, V
Published: (2021)

The role and impact of Del(5q) and TP53 mutations on haematopoietic stem and progenitor cells during the progression of Myelodysplastic Syndrome to Acute Myeloid Leukaemia
by: Doolittle, H
Published: (2017)

High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression.
by: Boultwood, J, et al.
Published: (2010)

High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression
by: Boultwood, J, et al.
Published: (2010)

Secondary acute myeloid leukaemia in children treated for acute lymphoblastic leukaemia.
by: Eden, O, et al.
Published: (1998)

Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia.
by: Guinn, B, et al.
Published: (2005)

Radiolabeled oligonucleotides targeting the RNA subunit of telomerase inhibit telomerase and induce DNA damage in telomerase-positive cancer cells
by: Jackson, MR, et al.
Published: (2019)

Immunological weapons against acute myeloid leukaemia.
by: Galea-Lauri, J
Published: (2002)

C/EBPalpha mutations in acute myeloid leukaemias.
by: Nerlov, C
Published: (2004)

EVI1 expression in acute myeloid leukaemia.
by: Langabeer, SE, et al.
Published: (2001)

Telomerase expression marks transitional growth-associated skeletal progenitor/stem cells: mTert marks skeletal progenitor/stem cells
by: Carlone, Diana L, et al.
Published: (2021)

Prediction of acute myeloid leukaemia risk in healthy individuals
by: Abelson, S, et al.
Published: (2018)

Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase.
by: Boultwood, J, et al.
Published: (2000)

Targeting telomerase with radiolabeled inhibitors.
by: Waghorn, P, et al.
Published: (2016)

Less utilized prognostic markers in acute myeloid leukaemia
by: Abdullah, Maha
Published: (2016)